CD8A and type 1 diabetes mellitus: Following activation with cross linked anti-CD3 mAb, the phosphorylation of Erk was lower in the RAGE–vs RAGE+ CD4+ and CD8+ T cells from T1D patients and healthy control subjects (****p<0.0001) (Fig 1C and 1D).